Several studies have evaluated the accuracy of SpHb by Pulse CO-Oximetry in adults in the operating room, intensive care unit, and emergency room, [2] [3] [4] but only 2 studies evaluated accuracy of trending or absolute accuracy in children. 5 A recent editorial has outlined how to properly perform accuracy method comparison studies. 6 The goal of this single-center prospective trial was to evaluate trending and absolute accuracy of SpHb in comparison with arterial Hb concentration measured by conventional hematology analyzer technology (Hb) in pediatric patients undergoing surgical procedures associated with substantial blood loss. Our additional goals were to identify significant predictors of SpHb error and to test if retrospective in vivo adjustment of the SpHb values (subtracting the bias of the first SpHb from the first Hb from all the following SpHb measurements) would improve the agreement of SpHb with Hb.
We hypothesized that continuous SpHb will display similar trending and absolute accuracy as Hb in pediatric patients during surgery in which case continuous Hb monitoring might complement intermittent blood sampling for surgical procedures with high blood loss.
BACKGROUND: Rainbow Pulse CO-Oximetry technology® (Masimo Corporation, Irvine, CA) provides continuous and noninvasive measurement of arterial hemoglobin concentration (SpHb). We assessed the trending and accuracy of SpHb by this innovative monitoring compared with Hb concentration obtained with conventional laboratory techniques (Hb) in children undergoing surgical procedures with potential for substantial blood loss. METHODS: Hb concentrations were recorded from Pulse CO-Oximetry and a conventional hematology analyzer. Regression analysis and 4-quadrant plot were used to evaluate the trending for changes in SpHb and Hb measurements (ΔSpHb and ΔHb). Bias, precision, and limits of agreement of SpHb and of in vivo adjusted SpHb (SpHb − first bias to HB) compared with Hb were calculated. RESULTS: One hundred fifty-eight SpHb-Hb data pairs and 105 delta pairs (ΔSpHb and ΔHb) from 46 patients aged 2 months to 17 years with Hb ranging from 16.7 to 7.9 g/dL were collected. To evaluate trending, the delta pairs (ΔSpHb and ΔHb) were plotted, which revealed a positive correlation (ΔSpHb = 0.022 + 0.76ΔHb) with correlation coefficient r = 0.76, 95% CI [confidence interval] = 0.57-0.86. The bias and precision of SpHb to Hb and in vivo adjusted SpHb were 0.4 ± 1.3 g/dL and 0.1 ± 1.2 g/dL, respectively; the limits of agreement were −2.0 to 3.2 g/dL before in vivo adjustment and −2.4 to 2.2 g/dL after in vivo adjustment (P value = 0.04). The mean percent bias (from the reference Hb concentration) decreased from 4.1% ± 11.9% to 0.7% ± 11.3% (P value = 0.01). No drift in bias over time was observed during the study procedure. Of patient demographic and physiological factors tested for correlation with the SpHb, only perfusion index at sensor site showed a weak correlation. CONCLUSIONS: The accuracy of SpHb in children with normal Hb and mild anemia is similar to that previously reported in adults and is independent of patient demographic and physiological states except for a weak correlation with perfusion index. The trending of SpHb and Hb in children with normal Hb and mild anemia showed a positive correlation. Further studies are necessary in children with moderate and severe anemia. 
METHODS
This prospective observational study was conducted at Cincinnati Children's Hospital Medical Center after IRB approval, and written parental/guardian consent as well as child assent was obtained. Patients weighing >3 kg and age up to 17 years undergoing major surgical procedures associated with substantial blood loss (e.g., cardiac surgery, liver and/or small bowel transplantation, multilevel spine surgery, craniofacial surgery, neurosurgery, and major abdominal or thoracic surgery) and who required an arterial catheter as a part of their standard care were recruited. Patients were excluded if they had a preexisting deformity or skin condition that would impede sensor placement, had allergies to the adhesive sensor material, or in the opinion of the study investigator were not suitable for participation in the study. Patient demographics, including age, weight, gender, ethnicity, medical diagnosis, and scheduled procedure were recorded. After induction of anesthesia and before the start of the procedure, an adhesive (R1 20L or R1 25L, revision E) or ReSposable (R2 20 or R2 25, revision E) noninvasive Hb (SpHb) sensor, connected to a Radical-7® Pulse CO-Oximeter, software version 7621 and 7801 (Masimo Corp., Irvine, CA), was placed on the proximal third of the nail bed of the second, third, or fourth finger of the hand on the same side as the arterial catheter of patients weighing >10 kg. In patients weighing from 3 to 9.9 kg, the sensor was placed on the proximal third of the nail bed of the great toe or thumb. The adhesive SpHb sensor is a single-piece tape-on sensor similar to a conventional Spo 2 sensor. The ReSposable sensor is a 2-part sensor composed of a reusable connector piece and a disposable piece that attaches to the patient's finger. The ReSposable and adhesive sensors use the same light-emitting diodes and signal-processing algorithms. An opaque shield covered the sensor to prevent optical interference. The Radical-7 device was connected to a laptop computer with data logging software (Automated Data Collection software, Masimo Corp.) for the continuous recording of SpHb and a signal quality indicator. The signal quality indicator depends on multiple factors such as perfusion at the sensor site, correct sensor placement, patient movement, and excessive room lights. If the SpHb value is displayed along with the indicator for low signal quality, it was duly noted. Arterial blood samples for analysis of total Hb concentration were obtained at the discretion of the anesthesiologist during each case and analyzed in the central laboratory with a Cell-Dyn Sapphire® hematology analyzer (Abbott Laboratories, Abbott Park, IL). The hematology analyzer was chosen as the reference method because studies have shown this Hb measurement methodology is in closer agreement with the "gold standard" for Hb measurement, the cyanmethemoglobin assay, 7 than other central laboratory measurement methodologies such as CO-oximetry. 8, 9 The hematology analyzer was calibrated after a single lot of samples was processed, as recommended by the manufacturer, and met the Clinical Laboratory Improvement Amendments proficiency testing criteria for acceptable analytical performance. The exact start time of each blood draw was recorded for comparison with the simultaneous SpHb value.
Statistical Analysis
Multiple studies have described the performance of continuous noninvasive Hb testing [2] [3] [4] [5] [6] 10 ; most recently, Riou 6 outlined guidelines on the design and analysis of such studies, which were considered in our study, design, and analysis.
Our primary end point was the comparison of magnitude and direction of change (trending) between the SpHb (ΔSpHb) test method and the Hb (ΔHb) reference method during surgery. Regression analysis with scatter plots for trending correlation was performed to calculate correlation coefficients (r) and coefficients of determination (R 2 ) with a 2-sided test, and the limits for the 95% CIs were reported. The effect of repeated measures on the correlation between test and reference method was evaluated by mixed effects regression analysis using standardized data.
Sensitivity of SpHb measurements to follow the correct directional trend change as determined by the Hb reference was calculated with 95% CIs. A generalized estimating equation (GEE)-type model was used to evaluate the impact of repeated measures on sensitivity results. We have used first-order autoregressive correlation structure for specifying the correlation for the repeated measurements. Trending results are reported for clinically significant directional changes (ΔHb >1 g/dL) and for all data, including minimal changes. Similar to our previous model, we used a mixed effects type of regression model to evaluate the influence of repeated measures per subject in the regression analyses.
Secondary end points were the absolute accuracy (bias) and precision (standard deviation) of the noninvasive Hb measurement (SpHb) compared with the reference method (Hb) and the evaluation of which variables may correlate significantly with the test method bias. Therefore, the error of the test method compared with the reference (bias) and its standard deviation were calculated. Bland-Altman graphs with limits of agreement and 2-sided 95% CIs corrected for multiple measures per subject 11 were created for the data set before and after in vivo adjustment. Linear regression or analysis of variance was performed as appropriate for patient demographics (weight, gender, ethnicity). Hb concentration was determined by the reference method, perfusion index, Fio 2 , and sensor type.
A regression analysis for bias against sample number was performed to assess whether there is a bias drift over time. A retrospective analysis of bias and precision of SpHb to Hb after in vivo adjustment of the SpHb values (in vivo adjusted SpHb = SpHb − first bias) allows the user to adjust the SpHb value manually to match an initial laboratory value so that all subsequent SpHb values are offset by the bias entered by the user. t test analysis was performed to assess the mean percent error before and after in vivo adjustment.
No a priori power analysis was performed because this was a substudy of a larger pulse CO-oximetry data collection effort. To address statistical significance of the results, P values and CIs for correlation coefficients and sensitivity values are reported.
RESULTS
Seventy subjects were enrolled in the study. Twenty-four were excluded from data analysis for various reasons
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Noninvasive Continuous Hemoglobin Monitoring in Children including age 18 years or older (N = 6), weight range outside that specified for the sensor used (i.e., wrong sensor applied N = 7), SpHb not captured by the computer (i.e., equipment malfunction N = 9), or all data points collected for the patient were associated with low signal confidence (N = 2). Of the remaining 46 patients, 17 were male, and the age ranged from 3 months to 17 years with an average of 11 years. There were 5 infants (1 month to 3 years), 19 children (4 years to 12 years), and 14 adolescents. The characteristics and procedures for the included patients are shown in Table 1 .
An average of 3 arterial blood samples (range of 1-7 samples) was obtained from each patient. Total Hb from the samples ranged from 7.9 to 16.7 g/dL by laboratory analysis (Hb) and 7.5 to 17.8 g/dL by SpHb. One hundred fifty-six SpHb-Hb data pairs were collected. Sixteen data sets were excluded due to no SpHb value (N = 6), low signal confidence of the SpHb value (N = 8), or no Hb value (N = 2); thus, 140 total data pairs from 46 patients were analyzed. Figure 1 shows the SpHb measurements plotted against Hb measurements, with a line for the regression (SpHb = 1.49 + 0.902Hb, correlation coefficient r = 0.700, 95% CI = 0.6-0.77) and lines for the paired values with a bias <1 g/dL, bias 1 to 2 g/dL, and bias >2 g/dL.
To evaluate trending, the delta pairs (ΔSpHb and ΔHb) were plotted, which revealed a positive correlation (ΔSpHb = 0.022 + 0.76ΔHb) with correlation coefficient r = 0.76, 95% CI = 0.57-0.86 (Fig. 2) . Mixed effects regression analysis with standardized data was performed to evaluate the possible effect of repeated measures on the correlation between SpHb and total Hb readings or on trending regression. In both cases, no significant effect could be detected because the regression coefficients are very similar and the differences are not statistically significant (P value = 0.547 and P value = 0.697, respectively). In the 4-quadrant plots, 40 data points were outside the exclusion zone of 1 g/d and not displayed in the plot (Fig. 3) ; 95% of data points were in the upper right and lower left quadrants, indicating appropriate changes in SpHb and Hb of the same direction. Therefore, the sensitivity of SpHb to correctly detect directional changes in Hb concentration as measured by the reference was 95% (95% CI = 0.83-0.99). With all data points included, sensitivity of SpHb was 76% (95% CI = 0.66-0.85). GEE analysis showed that multiple measures per subject did not significantly affect the sensitivity results.
To address the secondary end points, absolute bias ± precision of SpHb to Hb was 0.4 ± 1.3 g/dL. Retrospective in vivo adjustment of SpHb to Hb resulted in a bias ± precision of 0.1 ± 1.2 g/dL. Bland-Altman plots displayed limits of agreement of −2.0 to 3.2 g/dL before in vivo adjustment and −2.4 to 2.2 g/dL after in vivo adjustment (P = 0.04) (Fig. 4) . The mean percent bias (from the reference Hb concentration) decreased from 4.1% ± 11.9% to 0.7% ± 11.3% (P value = 0.01). No drift in bias over time was observed during the study procedure. Bias over Hb concentration at moderate anemia (Hb from 7 to 10 g/dL) or severe anemia (Hb <7 g/dL) could not be calculated because of small sample size (N = 28, Hb 7-10 g/dL).
Regression analysis to identify predictors of SpHb bias was performed for perfusion index, Hb concentration, age, weight, ethnicity, Fio 2 , and sensor type (resposable/disposable). None of these variables correlated significantly with SpHb bias with the exception of perfusion index (r = 0.3, P value = 0.002).
DISCUSSION
In this single-center study, we evaluated the trending and absolute accuracy of pulse CO-oximetry-derived Hb concentration (SpHb) compared with conventional hematology analyzer-derived Hb concentration in children undergoing surgery associated with blood loss. We also assessed the accuracy of SpHb to Hb before and after in vivo adjustment of SpHb (in vivo adjusted SpHb = SpHb − first bias). Retrospective analysis of in vivo adjustment was conducted in another study evaluating SpHb accuracy, but that study was conducted in adults, 12 whereas our study was in pediatrics. We found that SpHb followed the trend of Hb with a positive correlation with the same directionality in 95% of instances for Hb >10 g/dL, with good correlation (0.86). The trend accuracy using in vivo adjustment was better than absolute accuracy in terms of bias and limits of agreement. These findings suggest that noninvasive continuous Hb monitoring may help alert the clinician to directional changes of Hb values during blood loss for children with normal to mild anemia. Further studies are necessary to evaluate trending accuracy during blood loss for children with moderate to severe anemia.
The accuracy of SpHb in our study as evaluated by the bias, precision, and limits of agreement was similar to those previously found in the adults 2, 13 and in children undergoing neurosurgical procedures. 5 In these studies as well as our own, approximately two-thirds (68%) of the SpHb to Hb comparisons had a bias <1.3 g/dL and almost one-third had a bias >1.3 g/dL with a few percent >3 g/dL. In our study, however, we found that in vivo adjustment decreased the bias and limits of agreement, whereas the precision was not significantly affected.
Nevertheless, one-third of the in vivo adjustment comparisons had a bias >1.2 g/dL with a few percent >2 g/dL. Therefore, interpretation of the absolute SpHb with this version of the Pulse CO-Oximetry sensor (Revision E) must consider the large bias on almost one-third of the measurements. The improvement of bias and of the limits of agreement with the in vivo adjustment may enhance applicability of the technology because the anesthesiologist has greater certainty of Hb based on the SpHb providing reliable complementary information to intermittent Hb concentration measurements to aid decisions about sampling blood and transfusing blood.
The results of this study shared some similarities to a previous study in pediatric neurosurgical patients. 5 The correlation coefficients of changes in consecutive SpHb and Hb measurements in that study and in our study were similar (r = 0.8). Changes in SpHb and Hb were in the same direction 95% of the time in our study and 93% of the time in that study. 5 Overall, bias and precision were also similar: 0.4 ± 1.3 g/dL in our study versus 0.9 ± 1.4 g/dL in that study. There were several differences between the studies. The pediatric neurosurgical study observed a dependency of the bias with the Hb concentration, whereas our study did not. However, in our study, very few data points were in the low Hb ranges and predicting performance through regression analysis was not reliable. We included patients undergoing a variety of surgical procedures with a potential for substantial blood loss; therefore, our study provided a more general assessment of the performance of SpHb in pediatric surgery. Finally, our study assessed trending and included the in vivo adjustment of SpHb.
Limitations to our study include the nonrecruitment of neonates; thus, these data cannot be extrapolated to this population. A limited number of infants were studied, and thus there is less certainty of our findings in this age group. Our study included few values <10 g/dL so the performance of SpHb with moderate to severe anemia was not evaluated. 
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We evaluated potential predictors of SpHb bias including perfusion index, Fio 2 , patient demographics, and reference Hb concentration. Only perfusion index was found to be significant; however, the correlation was weak. A previous study by Miller et al. 10 in adults found a stronger correlation with perfusion index and bias, especially, a decrease of the bias with perfusion index >4.
Decisions to transfuse blood and to sample blood during our study were based on clinical judgment and by referring to values from the conventional hematology analyzer. SpHb values were not used to guide clinical decisions. Therefore, we did not evaluate the impact of this monitor on clinical care, such as the decision to transfuse or determine sampling of blood. However, in our study, SpHb accurately trended laboratory values in patients with mild anemia or normal Hb, in which accuracy was characterized by the precision being within 10% of the Hb value and the same directionality of change occurring in 95% of the occasions. Transfusion decisions typically occur during moderate and severe anemia. If there is the same trending for moderate to severe anemia, continuous SpHb measurements may offer a more timely indication of Hb changes to aid blood loss management; continuous SpHb is not intended to replace blood sampling altogether.
14 Two studies conducted in adult surgical patients 15, 16 suggest that SpHb monitoring may reduce red blood cell transfusions, not because fewer patients are transfused but because fewer units of blood are transfused in those who received transfusion. Further studies are necessary to better define the role of SpHb monitoring in blood management during surgery. 17 
CONCLUSIONS
In summary, our study found that noninvasive, continuous Hb monitoring by Pulse CO-Oximetry (SpHb) displayed similar trending and absolute accuracy in pediatric patients undergoing a variety of surgical procedures associated with blood loss as has been found in adult surgical patients. An adjustment of SpHb values by the first bias to Hb (in vivo adjustment) slightly improves the agreement of SpHb with laboratory values, yet one-third of the values can still reach a 2-g/dL difference with Hb over time. SpHb demonstrated good trending of measurements with invasive laboratory values on Hb measurements >10 g/dL. Therefore, trending SpHb values has the potential to supplement detection of changes of Hb concentration by invasive blood draws. Future studies should evaluate the performance of SpHb in neonates and infants, at lower levels of Hb (<10 g/dL) and the utility of SpHb for transfusion decision making. E DISCLOSURES Name: Mario Patino, MD. Contribution: This author helped design the study, conduct the study, data collection, data analysis, and manuscript preparation. Attestation: Mario Patino approved the final manuscript and attests to the integrity of the original data and the analysis reported in this manuscript. Name: Lindsay Schultz, BS. Contribution: This author helped conduct the study, data collection, data analysis, and manuscript preparation.
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